Skip to main content

Edotreotide

ADVERTISEMENT
Identification
Molecular formula
C60H82N12O19S2
CAS number
155931-05-4
IUPAC name
3-amino-4-[[2-[[1-[[2-[[2-[[1-[[2-[(2-amino-1-benzyl-2-oxo-ethyl)amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-2-oxo-1-[(4-sulfooxyphenyl)methyl]ethyl]amino]-4-oxo-butanoic acid
State
State

Edotreotide is usually in a solid state at room temperature when not dissolved. It is often stored as a lyophilized powder to preserve stability and potency. Proper storage in cool, dry environments away from direct sunlight is necessary to maintain its integrity.

Melting point (Celsius)
0.00
Melting point (Kelvin)
0.00
Boiling point (Celsius)
0.00
Boiling point (Kelvin)
0.00
General information
Molecular weight
1305.50g/mol
Molar mass
1 305.4970g/mol
Density
1.3000g/cm3
Appearence

Edotreotide typically appears as a white to off-white powder. It is often provided in a purified, crystalline form which may exhibit slight variations in texture depending on specific conditions of storage and processing. As with many peptide-based compounds, it is crucial to handle it with care to avoid contamination or degradation.

Comment on solubility

Solubility Insights for 3-amino-4-[[2-[[1-[[2-[[2-[[1-[[2-[(2-amino-1-benzyl-2-oxo-ethyl)amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-2-oxo-1-[(4-sulfooxyphenyl)methyl]ethyl]amino]-4-oxo-butanoic acid

The solubility of this complex compound is influenced by its multi-functional groups, which can interact with various solvents. Here are some important points to consider:

  • Hydrophilicity: The presence of multiple amino and sulfonic acid groups contributes to a high degree of hydrophilicity, which often promotes solubility in polar solvents like water.
  • Polar Solvents: This compound is likely to dissolve well in polar solvents due to its ionic and polar nature.
    For instance, it may exhibit good solubility in:
    • Water
    • Dimethyl sulfoxide (DMSO)
    • Methanol
  • Solvent Interactions: Its complex structure might lead to unique interactions within those solvents, potentially forming hydrogen bonds or ionic interactions.
  • Limitations in Non-Polar Solvents: Due to its polar functional groups, this compound is expected to have limited solubility in non-polar solvents such as hexane or toluene.

In summary, the solubility of this compound is high in polar solvents, supported by its functional diversity, but it will struggle in non-polar environments. This makes understanding its solubility profile essential for applications in pharmaceuticals and chemistry.

Interesting facts

Interesting Facts about 3-amino-4-[[2-[[1-[[2-[[2-[[1-[[2-[(2-amino-1-benzyl-2-oxo-ethyl)amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-2-oxo-1-[(4-sulfooxyphenyl)methyl]ethyl]amino]-4-oxo-butanoic acid

This complex molecule exhibits significant interest in the fields of medicinal chemistry and pharmacology. Its intricate structure is characterized by multiple functional groups, making it a prime candidate for targeted drug design. Here are some notable aspects:

  • Potential Anticancer Activity: The presence of indole and sulfooxyphenyl moieties hints at a possible role in cancer treatment, as compounds with similar structures have shown efficacy in inhibiting tumor growth.
  • Multifunctional Properties: The array of amine and carbonyl groups provides versatility in reactivity, which can be exploited in synthesizing more complex derivatives, enhancing their therapeutic potential.
  • Bioactivity Insight: Chemists are increasingly interested in understanding how such compounds interact with biological systems, particularly their binding efficacy to biomolecules.
  • Research Potential: Ongoing studies could reveal more about the mechanisms of action for related compounds, thus aiding in the development of new pharmaceuticals.

As chemists strive to unlock the mysteries of such intricate structures, they often quote Aristotle's wisdom: "Knowing yourself is the beginning of all wisdom." Understanding the properties and behaviors of compounds like this one empowers researchers to innovate and enhance our approaches to modern medicine.

In conclusion, the exploration of 3-amino-4-[[2-[[1-[[2-[[2-[[1-[[2-[(2-amino-1-benzyl-2-oxo-ethyl)amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-2-oxo-1-[(4-sulfooxyphenyl)methyl]ethyl]amino]-4-oxo-butanoic acid truly embodies the intersection of complexity and potential in chemical research.

Synonyms
C49H62N10O16S3
SCHEMBL1425223
HMS5087P12
PCK-4100-V
AKOS015896031
DB-046634
CCK-Octapeptide (26-33) (Sulfated Form)
3-amino-4-[[2-[[1-[[2-[[2-[[1-[[2-[(2-amino-1-benzyl-2-oxo-ethyl)amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-2-oxo-1-[(4-sulfooxyphenyl)methyl]ethyl]amino]-4-oxo-butanoic acid
CCK-8 (Sulfated Form) Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2, Cholecystokinin-8 sulfated, CCK-8S